Dn B Asset Management As Rigel Pharmaceuticals Inc Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 15, 2021
SELL
$3.35 - $4.93 $480,272 - $706,789
-143,365 Closed
0 $0
Q4 2020

Jan 19, 2021
SELL
$2.35 - $3.74 $6,970 - $11,092
-2,966 Reduced 2.03%
143,365 $501,000
Q3 2020

Oct 14, 2020
SELL
$1.78 - $4.13 $4,161 - $9,655
-2,338 Reduced 1.57%
146,331 $351,000
Q2 2020

Jul 08, 2020
BUY
$1.41 - $2.05 $7,202 - $10,471
5,108 Added 3.56%
148,669 $271 Million
Q4 2019

Jan 13, 2020
BUY
$1.6 - $2.43 $229,697 - $348,853
143,561 New
143,561 $307,000

Others Institutions Holding RIGL

# of Institutions
13
Shares Held
355K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.37B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email